Stableford Capital II LLC Has $1.81 Million Holdings in Elevance Health, Inc. (NYSE:ELV)

Stableford Capital II LLC increased its stake in Elevance Health, Inc. (NYSE:ELV - Free Report) by 84.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,256 shares of the company's stock after buying an additional 1,949 shares during the quarter. Stableford Capital II LLC's holdings in Elevance Health were worth $1,807,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Milestone Asset Management LLC raised its stake in Elevance Health by 2.2% in the 1st quarter. Milestone Asset Management LLC now owns 1,122 shares of the company's stock valued at $488,000 after acquiring an additional 24 shares during the period. Jacobi Capital Management LLC raised its stake in Elevance Health by 3.2% in the 4th quarter. Jacobi Capital Management LLC now owns 882 shares of the company's stock valued at $325,000 after acquiring an additional 27 shares during the period. McLean Asset Management Corp raised its stake in Elevance Health by 2.3% in the 1st quarter. McLean Asset Management Corp now owns 1,439 shares of the company's stock valued at $620,000 after acquiring an additional 32 shares during the period. Accurate Wealth Management LLC raised its stake in Elevance Health by 5.1% in the 1st quarter. Accurate Wealth Management LLC now owns 674 shares of the company's stock valued at $296,000 after acquiring an additional 33 shares during the period. Finally, Forum Financial Management LP raised its stake in Elevance Health by 1.2% in the 4th quarter. Forum Financial Management LP now owns 2,860 shares of the company's stock valued at $1,055,000 after acquiring an additional 34 shares during the period. Institutional investors and hedge funds own 89.24% of the company's stock.

Wall Street Analysts Forecast Growth

ELV has been the topic of a number of research analyst reports. Guggenheim restated a "buy" rating and issued a $518.00 price target on shares of Elevance Health in a research note on Wednesday, April 23rd. Barclays dropped their price target on Elevance Health from $522.00 to $480.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Argus set a $465.00 price target on Elevance Health in a research note on Friday, April 25th. Mizuho increased their price objective on Elevance Health from $455.00 to $505.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $478.00 price objective on shares of Elevance Health in a research report on Wednesday, June 4th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $498.87.

Elevance Health Stock Up 0.1%

Shares of NYSE ELV opened at $375.58 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.43 and a current ratio of 1.43. Elevance Health, Inc. has a 52 week low of $357.45 and a 52 week high of $567.26. The stock has a market capitalization of $84.86 billion, a P/E ratio of 14.65, a PEG ratio of 0.96 and a beta of 0.60. The stock's fifty day moving average is $400.00 and its 200 day moving average is $399.36.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The company reported $11.97 EPS for the quarter, topping analysts' consensus estimates of $10.60 by $1.37. Elevance Health had a return on equity of 18.61% and a net margin of 3.23%. The company had revenue of $48.77 billion for the quarter, compared to analysts' expectations of $46.26 billion. Sell-side analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Tuesday, June 10th will be given a $1.71 dividend. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date is Tuesday, June 10th. Elevance Health's payout ratio is currently 26.69%.

Insider Activity at Elevance Health

In related news, CFO Mark Kaye sold 4,588 shares of the firm's stock in a transaction dated Thursday, April 24th. The stock was sold at an average price of $424.82, for a total value of $1,949,074.16. Following the sale, the chief financial officer now directly owns 18,977 shares of the company's stock, valued at $8,061,809.14. This trade represents a 19.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.29% of the stock is currently owned by insiders.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.